default author photo

Daphne W. Dumoulin

Erasmus University Rotterdam (EUR) - Department of Pulmonary Medicine

Rotterdam

Netherlands

  • Erasmus University Rotterdam (EUR) - Department of Pulmonary Medicine

SCHOLARLY PAPERS

3

DOWNLOADS

111

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Lurbinectedin Shows Clinical Activity and Immune-Modulatory Functions in Patients with Pre-Treated Small Cell Lung Cancer and Malignant Pleural Mesothelioma

Number of pages: 41 Posted: 21 Apr 2022
Daphne W. Dumoulin, L. Cantini, R. Cornelissen, Madelief Vink, Larissa Klaase, N. Tebayna, Joanne M. Mankor, S.J. Baart, Rudi Hendriks, A-M.C. Dingemans, Marcella Willemsen and Joachim G. Aerts
Erasmus University Rotterdam (EUR) - Department of Pulmonary Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), University Medical Center Rotterdam - Department of Pulmonary Medicine, affiliation not provided to SSRN, affiliation not provided to SSRN, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), University Medical Center Rotterdam - Department of Pulmonary Medicine, Erasmus University Rotterdam, affiliation not provided to SSRN and Erasmus University Rotterdam (EUR) - Department of Pulmonary Diseases
Downloads 48 (1,097,529)

Abstract:

Loading...

lurbinectedin, small cell lung cancer/SCLC, malignant pleural mesothelioma/MPM, Immunotherapy, immune monitoring

2.

Model-Informed Approaches to Develop Cost-Saving Dosing Strategies for Pembrolizumab

Number of pages: 20 Posted: 17 Apr 2026
Yan Wang, Laura H. Bukkems, J.G. Coen van Hasselt, Marie-Rose Crombag, Daphne W. Dumoulin, Jeroen J.M.A Hendrikx, W.S.M.E. Theelen, Tom van der Hulle, Ellen Kapiteijn, Juliëtte Zwaveling, Annemarie Becker, T.Jeroen N. Hiltermann, Lizza E.L. Hendriks, Robin van Geel, Wouter H. van Geffen, Michel van den Heuvel, Thijs H. Oude Munnink, Egbert Frederik Smit, Henk-Jan Guchelaar, Dirk Jan Moes and Rob ter Heine
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Erasmus University Rotterdam (EUR) - Department of Pulmonary Medicine, affiliation not provided to SSRN, Netherlands Cancer Institute Antoni van Leeuwenhoek, affiliation not provided to SSRN, Leiden University Medical Centre, Leiden University - Leiden University Medical Center (LUMC), Amsterdam Academic Medical Center, University of Groningen - Department of Pulmonary Diseases, Maastricht University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Groningen - University Medical Center Groningen, affiliation not provided to SSRN, Leiden University - Department of Clinical Pharmacy and Toxicology, Leiden University - Department of Clinical Pharmacy and Toxicology and Radboud University Nijmegen - Department of Pharmacy and Radboud Center for Infectious Diseases
Downloads 32 (1,359,097)

Abstract:

Loading...

pembrolizumab, pharmacokinetics, modeling and simulation, cost-effectiveness

3.

Outcome and Safety of Lurbinectedin as Compassionate Use in Extensive Stage Small Cell Lung Cancer: A Multicentric International Cohort

Number of pages: 22 Posted: 02 Jun 2025
Daniela Scattolin, A-M.C. Dingemans, Alessandro Dal Maso, Valentina Guarneri, Joachim G. Aerts, Giulia Pasello and Daphne W. Dumoulin
affiliation not provided to SSRN, Erasmus University Rotterdam, Istituto Oncologico Veneto – IRCCS, affiliation not provided to SSRN, Erasmus University Rotterdam (EUR) - Department of Pulmonary Diseases, affiliation not provided to SSRN and Erasmus University Rotterdam (EUR) - Department of Pulmonary Medicine
Downloads 31 (1,304,549)

Abstract:

Loading...

small cell lung cancer, lurbinectedin, real-world, effectiveness